Vantage Fortian/Orian 1.5T, MRT-1550, V9.0 with AiCE Reconstruction Processing Unit for MR
Canon Medical Systems Corporation • Radiology • 04/12/2024
Device Purpose
The Vantage Fortian/Orian 1.5T, MRT-1550, V9.0 system is a magnetic resonance imaging device designed to produce high-quality diagnostic images of the head and body using a 1.5T magnet and various NMR pulse sequences. This updated version significantly enhances image quality and workflow efficiency through the integration of advanced software features, including multiple Deep Learning and Machine Learning algorithms for image reconstruction, motion correction, and automated scan planning.
Summary
The Vantage Fortian/Orian 1.5T, MRT-1550, V9.0 is a 1.5 Tesla Magnetic Resonance Imaging (MRI) system designed for diagnostic imaging. It produces cross-sectional (transaxial, coronal, sagittal, oblique) images of anatomic structures of the head or body, including non-contrast enhanced imaging like MRA. The system utilizes nuclear magnetic resonance (NMR) principles, detecting signals based on proton density, T1 and T2 relaxation times, flow dynamics, and chemical shift to generate images. These images, when interpreted by a trained physician, aid in diagnosis. The system features a 1.4m short bore magnet (either 3.8 or 4.1 tons depending on the model), Canon's Pianissimo noise reduction technology, and a maximum field of view of 55x55x50 cm, with options for standard or XGO gradient systems. Version 9.0 introduces significant software and accessory enhancements, many leveraging Deep Learning (DL) and Machine Learning (ML). Key software updates include: Exsper for 3D encoding; Slice Shimming for improved magnetic field homogeneity; Iterative Motion Correction (IMC) now using DL for artifact reduction; Free Breathing Dynamic imaging with DL reconstruction for patients unable to hold their breath; UTE imaging with CG-Recon for faster scans; and the Precise IQ Engine (PIQE), a DL tool to generate higher resolution images from lower matrix inputs for brain and knee, reducing ringing artifacts and improving sharpness. Automation features like Auto Protocol Brain Application, Auto Consult Brain Package, NeuroLine+ (ML-based), and Auto Scan Assist aim to streamline workflow and standardize examinations. Accessory changes include an updated Tablet UX for enhanced patient interaction and scan control, a 10GbE high-speed reconstruction kit for the AiCE unit, and an improved ceiling camera for patient positioning. Extensive bench and clinical testing confirmed these features met performance and image quality criteria, with DL/ML components validated on data independent of training sets.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance of the Deep Learning-based Iterative Motion Correction (IMC) in V9.0 compare quantitatively to the traditional model-based methods in previous versions, particularly in scenarios with complex or severe patient motion?; What is the specific impact of the Precise IQ Engine (PIQE) on diagnostic accuracy or confidence for subtle pathologies in brain and knee imaging, beyond general image quality improvements?; For the Free Breathing Dynamic imaging with Deep Learning reconstruction, what is the range of acquisition times achieved, and how does it compare to conventional breath-hold techniques in terms of temporal resolution for dynamic contrast-enhanced liver studies?; How does the updated NeuroLine+ (Machine Learning-based) perform in terms of slice alignment accuracy and consistency across diverse patient anatomies and pathologies compared to experienced technologist manual planning?; What are the computational overheads and reconstruction time differences introduced by the new Deep Learning features (PIQE, DL-IMC, Free Breathing Dynamic DLR), and how does the 10GbE high-speed reconstruction kit mitigate these?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, HBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly